{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:20:30Z","timestamp":1783430430033,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH (NIDDK)","award":["K24-DK091419"],"award-info":[{"award-number":["K24-DK091419"]}]},{"name":"NIH (NIDDK)","award":["R01-DK078106"],"award-info":[{"award-number":["R01-DK078106"]}]},{"name":"DaVita Clinical Research"},{"name":"National Institute on Aging of the National Institutes of Health","award":["R21AG047036"],"award-info":[{"award-number":["R21AG047036"]}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bone.2014.01.016","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T08:02:54Z","timestamp":1390982574000},"page":"201-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients"],"prefix":"10.1016","volume":"61","author":[{"given":"Elani","family":"Streja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Ling","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos Z.","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongha","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.01.016_bb0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5414\/CNP73268","article-title":"Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease","volume":"73","author":"Kovesdy","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0010","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.01.016_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0020","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0025","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.01.016_bb0030","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.01.016_bb0035","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/j.ajkd.2008.05.020","article-title":"Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study","volume":"52","author":"Wald","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0045","series-title":"Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol dial transplant","author":"Fouque","year":"2012"},{"key":"10.1016\/j.bone.2014.01.016_bb0050","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.01.016_bb0055","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gfr747","article-title":"Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease","volume":"27","author":"Lukowsky","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.01.016_bb0060","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0065","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.bone.2014.01.016_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0075","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1038\/ki.2011.27","article-title":"Phosphate and FGF-23","author":"Juppner","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.bone.2014.01.016_bb0080","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.ajkd.2008.12.002","article-title":"Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story","volume":"53","author":"Kalantar-Zadeh","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.108.807362","article-title":"Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis","volume":"119","author":"Kalantar-Zadeh","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bone.2014.01.016_bb0090","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.ajkd.2011.03.018","article-title":"Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis","volume":"58","author":"Mehrotra","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0095","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwr384","article-title":"Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis","volume":"175","author":"Kalantar-Zadeh","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bone.2014.01.016_bb0100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1600-6143.2011.03468.x","article-title":"Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients","volume":"11","author":"Molnar","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bone.2014.01.016_bb0105","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/kisup.2013.96","article-title":"Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients","volume":"Suppl. 3","author":"Streja","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.01.016_bb0110","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.bone.2014.01.016_bb0115","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1681\/ASN.2011101002","article-title":"Is the malnutrition-inflammation complex the secret behind greater survival of African-American dialysis patients?","volume":"22","author":"Kalantar-Zadeh","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0120","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/ndt\/gft213","article-title":"Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients","volume":"28","author":"Park","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.01.016_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semnephrol.2008.10.002","article-title":"Why is protein-energy wasting associated with mortality in chronic kidney disease?","volume":"29","author":"Kovesdy","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pcad.2013.10.005","article-title":"Obesity paradox in end-stage kidney disease patients","volume":"56","author":"Park","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.bone.2014.01.016_bb0135","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/ndt\/gfp260","article-title":"The association between parathyroid hormone and mortality in dialysis patients is modified by wasting","volume":"24","author":"Drechsler","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.bone.2014.01.016_bb0140","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.01.016_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinternmed.2007.110","article-title":"Association of activated vitamin D treatment and mortality in chronic kidney disease","volume":"168","author":"Kovesdy","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bone.2014.01.016_bb0150","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1681\/ASN.2007111164","article-title":"Association of oral calcitriol with improved survival in nondialyzed CKD","volume":"19","author":"Shoben","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0155","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: a historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0160","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.bone.2014.01.016_bb0165","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/pds.3349","article-title":"Administered paricalcitol dose and survival in hemodialysis patients: A marginal structural model analysis","volume":"21","author":"Miller","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bone.2014.01.016_bb0170","series-title":"Annual data report: atlas of end-stage renal disease in the United States","author":"USRDS","year":"2013"},{"key":"10.1016\/j.bone.2014.01.016_bb0175","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1681\/ASN.2010121224","article-title":"FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis","volume":"22","author":"Kendrick","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.bone.2014.01.016_bb0180","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2014.01.016_bb0185","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.01.016_bb0190","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-139X.2011.00968.x","article-title":"Emerging importance of residual renal function in end-stage renal failure","volume":"24","author":"Vilar","year":"2011","journal-title":"Semin Dial"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T21:53:29Z","timestamp":1538862809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":38,"alternative-id":["S8756328214000180"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.01.016","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}